Deal
Daiichi Sankyo signs agreement with Japan to supply COVID-19 vaccine
Daiichi Sankyo partners with Japan’s Ministry of Health, Labour, and Welfare to provide 1.4 million doses of its DS-5670 omicron-adapted mRNA COVID-19 vaccine, pending approval. Read More>>
Centre Setup and Expansion
Novo Nordisk expands site to manufacture GLP-1 drugs
Novo Nordisk plans a US$ 2.29 Billion expansion of its production facility in Chartres, France, focusing on GLP-1 products, including Ozempic. The investment involves extending the quality control lab, adding aseptic production, and finishing production processes. Read More>>
Executive Movement
Neuland Laboratories Appoints Dr. Sharadsrikar V. Kotturi as Chief Scientific Officer
With a PhD in chemistry and over 20 years of R&D experience, Dr. Kotturi’s expertise spans Discovery and Development, Analytical R&D, and sustainable chemistries. Read More>>
Merger and Acquisition
Astellas Pharma Acquires Propella Therapeutics, Secures Prostate Cancer Drug
Astellas Pharma acquires Propella Therapeutics for US$ 175 million, securing access to PRL-02, an innovative injectable androgen biosynthesis inhibitor for prostate cancer. Read More>>
New Product Development and Product Launch
Grifols Unveils sCD38 Solution Enhancing Blood Transfusion Testing
Grifols introduces Grifols sCD38, the first soluble recombinant protein, addressing interference issues in blood transfusion tests for multiple myeloma patients on daratumumab therapy. Read More>> |